Synergistic Effects of Doxorubicin and Quercetin on ROS-Associated Apoptosis and EGFR/FOXP3 Modulation in OVCAR3 Cells
Elif Ozan, Mehmet Cudi Tuncer, İlhan Özdemir · 2026
Read Synergistic Effects of Doxorubicin and Quercetin on ROS-Associated Apoptosis and EGFR/FOXP3 Modulation in OVCAR3 Cells by Elif Ozan, Mehmet Cudi Tuncer, İlhan Özdemir (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13297588.txt.
Description
Elif Ozan, Mehmet Cudi Tuncer, and İlhan Özdemir test a plant compound as a partner for a standard cancer drug in ovarian cancer cells, in a 2026 study. The compound, quercetin, is a common plant pigment that steers stress and cell-death pathways. Pairs of the drug doxorubicin and quercetin were tried on OVCAR3 cancer cells, with normal skin cells as a safety check.
The pair killed cancer cells more than either agent alone, a true synergy by the maths used. Cell death programmes switched on strongly, execution enzymes rose, and reactive oxygen inside the cells climbed nearly sevenfold. Two growth-linked genes quieted. Normal skin cells withstood both agents better, hinting at a safety margin, though the authors call that hint early and unproven in animals.
Catalog record
| CREATOR | Elif Ozan, Mehmet Cudi Tuncer, İlhan Özdemir |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 54 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |